The global spinal muscular atrophy treatment market is positioned to grow through 2021, due to a growing number of SMA cases and rising awareness about diagnostic and treatment options, based on a Persistence Market Research report, according to medGadget.
Here are five observations:
1. Other market drivers include supportive government initiatives and enhanced healthcare infrastructure.
2. A lack of trained professionals in physiotherapy regimens as well as costliness of treatments will hinder market growth.
3. North America currently leads the global market, because of the number of SMA cases as well as available treatments.
4. Asia and Europe will both likely witness significant market growth in the coming years.
5. China and India will see the fastest growth, due to a growing number of patients as well as an increasing number of government initiatives.